First Space San Carlos, California First Space San Carlos, California [Member] First Space San Carlos, California Less: Accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Statistical Measurement [Domain] Statistical Measurement [Domain] Property and equipment, net Business Combination, Recognized Asset Acquired, Property, Plant, and Equipment Schedule of Available-for-Sale Securities Debt Securities, Available-for-Sale [Table Text Block] Business Combination, Separately Recognized Transaction [Table] Business Combination, Separately Recognized Transaction [Table] Decrease in net loss per share ( in dollars per share) Increase (Decrease) in Net Income (Loss) Per Share Amount of increase (decrease) in net income (loss) per share during the reporting period. Award Timing Predetermined Award Timing Predetermined [Flag] 2026 (remaining 9 months) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Entity File Number Entity File Number Additional Paid-in Capital Additional Paid-in Capital [Member] Tabular List, Table Tabular List [Table Text Block] Leases [Abstract] Leases [Abstract] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Write-offs Financing Receivable, Allowance for Credit Loss, Writeoff Accounts payable Increase (Decrease) in Accounts Payable Foresight Diagnostics’ indebtedness settled by the Company Business Combination, Consideration Transferred, Liabilities Incurred Performance-based awards and restricted stock units Share-Based Payment Arrangement [Member] Goodwill [Line Items] Goodwill [Line Items] Gross Unrealized Loss Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Medicare Medicare [Member] Represents Medicare national health insurance program of the United States government. Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Basic (in dollars per share) Earnings Per Share, Basic Adjustment to Compensation: Adjustment to Compensation [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Financial Liabilities: Liabilities, Fair Value Disclosure [Abstract] Revenue Recognition Revenue from Contract with Customer [Text Block] License and trademarks License and Trademarks [Member] License and Trademarks Revenue recognized from performance obligations satisfied within the same period Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized Consideration for business combination Issuance of Common Stock for Business Acquisition Issuance of Common Stock for Business Acquisition Schedule of Segment Reporting Schedule of Segment Reporting Information, by Segment [Table Text Block] Short-term debt financing Outstanding balance Short-Term Debt Vesting of restricted stock units (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Test Revenue Test Revenue [Member] Represents tests delivered in prior periods that were fully collected. Lease space (area) Area of Real Estate Property Revenue, remaining performance obligation Revenue, Remaining Performance Obligation, Amount Adjustment to Compensation, Amount Adjustment to Compensation Amount Concentration risk (as a percent) Concentration Risk, Percentage Principles of Consolidation Consolidation, Policy [Policy Text Block] Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Increase in deferred revenues Contract with Customer, Liability, Increase from Deferred Revenue The additional amount of obligation to transfer good or service to customer for which consideration has been received or is receivable. Investment in related party Investment In Related Party Amount of investment in related party. Options to purchase common stock Share-Based Payment Arrangement, Option [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Amount awarded from other party Litigation Settlement, Amount Awarded from Other Party Antidilutive Securities [Axis] Antidilutive Securities [Axis] Impairment charge Asset Impairment Charges Total stockholders’ equity Beginning balance Ending balance Equity, Attributable to Parent Debt Securities, Available-for-Sale [Table] Debt Securities, Available-for-Sale [Table] Insider Trading Policies and Procedures [Line Items] Stock-based compensation expense Share-Based Payment Arrangement, Expense Estimated fair value of the adjustment escrow shares Business Combination Consideration Transferred Estimated Fair Value Of Adjustment Escrow Shares Business Combination Consideration Transferred Estimated Fair Value Of Adjustment Escrow Shares Schedule of Property and Equipment, Net Property, Plant and Equipment [Table Text Block] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Goodwill and Intangible Assets Disclosure [Abstract] Current assets: Assets, Current [Abstract] Options forfeited/cancelled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Total liabilities and stockholders’ equity Liabilities and Equity Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Cash, cash equivalents, and restricted cash Cash, Cash Equivalents, and Restricted Cash [Member] Represents cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Issuance of common stock pursuant to asset acquisition, net (in shares) Stock Issued During Period, Shares, Acquisitions Number of Shares Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Risk and Uncertainties Concentration Risk, Credit Risk, Policy [Policy Text Block] Purchases of property and equipment in accounts payable and accruals Purchases Of Property And Equipment In Accounts Payable And Accruals Represents purchases of property and equipment in accounts payable and accruals. Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] Cover [Abstract] Cover [Abstract] Cash, cash equivalents and restricted cash Cash and Cash Equivalents, Fair Value Disclosure Clinical samples payable Clinical Samples Payable Clinical Samples Payable Maximum Maximum [Member] Estimated useful life (in years) Finite-Lived Intangible Asset, Useful Life Accounting Policies [Abstract] Accounting Policies [Abstract] Inivitae Patent Case Inivitae Patent Case [Member] Represents Inivitae Patent Case. Total Intangible Assets, net Finite-Lived Intangible Assets, Net Collateral amount Debt Instrument, Collateral Amount Schedule of Future Minimum Lease Payments Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Debt Instrument [Line Items] Debt Instrument [Line Items] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Pay vs Performance Disclosure [Line Items] Total operating lease liabilities Operating Lease, Liability Genosity Inc. Patent Case Genosity Inc. Patent Case [Member] Represents Genosity Inc. Patent Case. Series B Preferred Stock Series B Preferred Stock [Member] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount NeoGenomics Patent Case NeoGenomics Patent Case [Member] Represents NeoGenomics patent case. Business Combination Business Combination [Text Block] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Developed technology intangible asset Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Developed Technology Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Developed Technology Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Entity Shell Company Entity Shell Company Other liabilities Other Liabilities, Noncurrent Schedule of Long-Term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Approximate percentage of revenue collected within 9 months Approximate Percentage Of Revenue Collected Within Nine Months Approximate percentage of revenue collected within 9 months. Non-cash expense recovery Noncash Expense Recovery Amount of noncash expense recovery. Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Company Selected Measure Amount Company Selected Measure Amount 2029 Lessee, Operating Lease, Liability, to be Paid, Year Three Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Other long-term liabilities Increase (Decrease) in Other Noncurrent Liabilities Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Number of patent litigations Loss Contingency, Patents Litigations, Number Number of patent litigations. Name Measure Name Number of lawsuits Loss Contingency, Number of Lawsuits Loss Contingency, Number of Lawsuits Laboratory instruments supplier Laboratory Instruments [Member] Represents a contractual commitment to purchase laboratory instruments. Summary of Stock-Based Compensation Expenses Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Operating lease liabilities, current portion Operating lease liabilities, current portion included in other accrued liabilities Operating Lease, Liability, Current Proceeds from maturity of investments Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale Purchased and capitalized software held for internal use Software and Software Development Costs [Member] Document Fiscal Period Focus Document Fiscal Period Focus BGI Genomics BGI Genomics Co., Ltd. [Member] Represents BGI Genomics Co., Ltd. Aggregate grant date fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Grants in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Grants in Period Award Timing Method Award Timing Method [Text Block] Litigation Case [Domain] Litigation Case [Domain] Award Type Award Type [Axis] Deferred revenue, long-term portion Contract with Customer, Liability, Noncurrent Legal Entity [Axis] Legal Entity [Axis] Total assets Assets Investment, Name [Domain] Investment, Name [Domain] 2027 Finite-Lived Intangible Asset, Expected Amortization, Year One Trading Symbol Trading Symbol 2030 Lessee, Operating Lease, Liability, to be Paid, Year Four Annual lease payment Lessee, Operating Lease, Annual Rent Expense Represents the annual payment that the lessee is obligated to make in connection with a property under the terms of an agreement classified as an operating lease. Business Combinations Business Combination [Policy Text Block] Awards vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Geographical [Domain] Geographical [Domain] Material suppliers Inventory Material Purchase Commitment [Member] Represents a contractual commitment to purchase from suppliers. Gross margin percentage Gross Margin Percentage The percentage of a company's revenue that remains after subtracting the cost of goods sold. Financing Receivable, Allowance for Credit Loss [Roll Forward] Financing Receivable, Allowance for Credit Loss [Roll Forward] Entity Address, City or Town Entity Address, City or Town Operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Statement of Income Location, Balance [Domain] Statement of Income Location, Balance [Domain] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Financial Assets: Assets, Fair Value Disclosure [Abstract] 2030 Finite-Lived Intangible Asset, Expected Amortization, Year Four Entity Emerging Growth Company Entity Emerging Growth Company Warrant Warrant [Member] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Available-for-sale Securities Debt Securities, Available-for-Sale [Line Items] Outstanding, beginning balance (in shares) Outstanding, end balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Level 2 Fair Value, Inputs, Level 2 [Member] Carrying amount of investments Equity Method Investments Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Business Combination [Domain] Business Combination [Domain] Operating Leases Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Billing collection period (in months) Billing Average Collection Period Represents the average collection period for billing. Change in fair value of warrants and preferred stock of related party equity investment Fair Value Adjustment of Warrants PEO PEO [Member] Number of lawsuits Loss Contingency, Pending Claims, Number Schedule of Operating Lease Liabilities Assets and Liabilities, Lessee [Table Text Block] Assets and Liabilities, Lessee Operating lease right-of-use assets Increase Decrease In Operating Lease Right Of Use Assets Amount of increase (decrease) in operating lease right-of-use assets. United States UNITED STATES Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Issuance of common stock upon exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Schedule of Estimated Future Aggregate Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Accumulated Deficit Retained Earnings [Member] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Schedule of Other Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Share-Based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Income Statement [Abstract] Income Statement [Abstract] Cash, cash equivalents and restricted cash Cash, cash equivalents and restricted cash, beginning of period Cash, cash equivalents and restricted cash, end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Liability-Classified Awards Liability-Classified Awards [Member] Liability-Classified Awards Warrants Derivative Asset Income tax expense Income tax expense Income Tax Expense (Benefit) Spread on interest rate (as a percent) Debt Instrument, Basis Spread on Variable Rate Intangible assets Intangible Assets, Net (Excluding Goodwill) Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Acquisition related costs recorded Acquisition Related Costs Recorded On Balance Sheet Acquisition Related Costs Recorded On Balance Sheet Product and Service [Domain] Product and Service [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Customer Concentration Risk Customer Concentration Risk [Member] Contingent consideration Contingent Consideration [Member] Contingent Consideration Long-Term Purchase Commitment [Table] Long-Term Purchase Commitment [Table] Guardant Case Guardant, Inc. Case [Member] Represents Guardant, Inc. case. Property and equipment, gross Property, Plant and Equipment, Gross Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Total financial liabilities Liabilities, Fair Value Disclosure Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Accrued shipping charges Accrued Shipping Charges Carrying value as of the balance sheet date of obligations incurred through that date and payable for shipping charges. Proceeds from exercise of stock options Proceeds from Stock Options Exercised City Area Code City Area Code Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Balance (in shares) Balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Ravgen Patent Case Ravgen Patent Case [Member] Represents Ravgen Patent Case. Schedule of Changes in the Balance of Deferred Revenues Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Discount rate used Discount Rate Used To Determine Fair Value Discount Rate Used To Determine Fair Value Net cash provided by operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Potential payments to third party vendor Potential payments to third party vendor Amount of potential milestones payable to other party. Useful Life Property, Plant and Equipment, Useful Life Subsequent Event Subsequent Event [Member] Selling, general and administrative Selling, General and Administrative Expenses [Member] Lease expense Lease, Cost Current assets Business Combination, Recognized Asset Acquired, Other Asset, Current Cost of revenues Cost of Sales [Member] Goodwill Goodwill Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Asia Pacific and Other Asia Pacific and Other [Member] PEO Total Compensation Amount PEO Total Compensation Amount Long-Term Debt, Type [Axis] Long-Term Debt, Type [Axis] Purchase Commitment, Excluding Long-Term Commitment [Axis] Purchase Commitment, Excluding Long-Term Commitment [Axis] Depreciation expense Depreciation 2026 (remaining 9 months) Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Equity Components [Axis] Equity Components [Axis] Property and Equipment, net Property, Plant and Equipment [Line Items] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Concentration Risk [Table] Concentration Risk [Table] Product revenues Product [Member] Cash payment for fractional shares Business Combination Consideration Transferred Cash Payment For Fractional Shares Business Combination Consideration Transferred Cash Payment For Fractional Shares Number of reporting segments Number of Reportable Segments Supplemental disclosure of cash flow information: Supplemental Cash Flow Information [Abstract] Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost Other Performance Measure, Amount Other Performance Measure, Amount Weighted- Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Schedule of Material Contractual Commitments Contractual Obligation, Fiscal Year Maturity [Table Text Block] Entity Address, State or Province Entity Address, State or Province Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Security, Excluded EPS Calculation [Table] Fair Value Fair Value Measurement, Policy [Policy Text Block] Shares deposited in escrow account for purchase price adjustments, returned (in shares) Number Of Shares Deposited In Escrow Account For Purchase Price Adjustments, Returned Number Of Shares Deposited In Escrow Account For Purchase Price Adjustments, Returned Total current liabilities Liabilities, Current MyOme, Inc. MyomeInc [Member] Represents MyOme, Inc. Individual: Individual [Axis] Research and development Research and Development Expense [Member] Additional paid-in capital Additional Paid in Capital, Common Stock Investment commitments Investment Commitments Equity Securities Without Readily Determinable Fair Value Amount of investment commitments for investment in equity security without readily determinable fair value. Marketing and corporate affairs Accrued Marketing Costs, Current Entity [Domain] Entity [Domain] Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activity Clinical samples and data for oncology development Clinical samples and data for oncology development [Member] Represents a contractual commitment to purchase clinical samples and data for oncology development. Document Fiscal Year Focus Document Fiscal Year Focus Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Asset acquisition upfront consideration transferred Asset Acquisition Upfront Consideration Transferred Asset Acquisition Upfront Consideration Transferred Entity Interactive Data Current Entity Interactive Data Current Non-cash lease expense Operating Lease, Cost Deferred tax liability, long-term portion Deferred Tax and Other Liabilities, Noncurrent Steve Chapman [Member] Steve Chapman Acquisition related costs Business Combination, Acquisition-Related Cost, Expense RSU and performance-based awards Restricted Stock Units, RSU and Performance Shares [Member] Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met and share-based payment arrangement awarded for meeting performance target. Accrued charges for third-party testing Accrued Charges For Outsourced Testing Carrying value as of the balance sheet date of obligations incurred through that date and payable for outsourced testing. Issuance of common stock upon exercise of stock options (in shares) Options exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Accrued settlement liability Estimated Litigation Liability Goodwill and Intangible Assets Goodwill and Intangible Assets, Policy [Policy Text Block] Laboratory and Office Spaces Building [Member] Total commitments Purchase Obligation Segment Reporting Segment Reporting Disclosure [Text Block] Noncash operating activities related to right-of-use assets Noncash Operating Activities Related To Right Of Use Assets Noncash operating activities related to right-of-use assets. Goodwill [Table] Goodwill [Table] UBS Credit Line UBS Credit Line [Member] Represents the 2015 Line of Credit entered into by the entity. Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Fair value of contingent consideration Business Combination, Contingent Consideration, Liability Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Amortization of acquired intangible assets Amortization of Intangible Assets Selling, general and administrative Selling, General and Administrative Expense Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Depreciation and amortization Depreciation, Depletion and Amortization Other assets Other Assets, Noncurrent Customer [Domain] Customer [Domain] Entity Central Index Key Entity Central Index Key Reserves for refunds to insurance carriers Accrued Insurance PEO Name PEO Name Agreement term Agreement Term Period the agreement term, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Revolving Credit Facility Revolving Credit Facility [Member] Accounts Receivable, net of allowance Accounts Receivable [Policy Text Block] Acquired clinical samples and data for oncology development Payments For Clinical Samples And Data For Oncology Development The cash outflow for clinical samples and data for oncology development. Patients Patients [Member] Patients group of customers. Contingent consideration payable, long-term portion Business Combination, Contingent Consideration, Liability, Noncurrent Arrangement Duration Trading Arrangement Duration Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Increased revenue Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price Inivata Patent Case Inivata Patent Case [Member] Represents Inivata patent case. Computer equipment Computer Equipment [Member] Deferred revenue, current portion Contract with Customer, Liability, Current Segments [Axis] Segments [Axis] Warrants exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Cancellation of escrow shares pursuant to business combination, net (in shares) Escrow Shares Cancelled, Shares Escrow Shares Cancelled, Shares Exercise Price Award Exercise Price Entity Filer Category Entity Filer Category Class of Stock [Domain] Class of Stock [Domain] Local Phone Number Local Phone Number Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Shares conversion ratio (in shares) Business Combination Shares Conversion, Conversion Ratio Business Combination Shares Conversion, Conversion Ratio Subsequent Event Type [Axis] Subsequent Event Type [Axis] Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Contingent consideration payable, current portion Business Combination, Contingent Consideration, Liability, Current Cash and cash equivalents Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent Assets Assets [Abstract] Credit Facility [Axis] Credit Facility [Axis] Underlying Security Market Price Change Underlying Security Market Price Change, Percent 2029 Finite-Lived Intangible Asset, Expected Amortization, Year Three Debt Instrument [Axis] Debt Instrument [Axis] Awards forfeited/cancelled (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Fair Value Measurements Fair Value Disclosures [Text Block] Credit Facility [Domain] Credit Facility [Domain] Total Finite-Lived Intangible Assets, Gross Stockholders’ equity: Equity, Attributable to Parent [Abstract] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Non-cash settlement expense Non-Cash Stock Settlement Expense Non-Cash Stock Settlement Expense Vesting percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Research and development Research and Development Expense Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Warrants term Class of Warrant or Right, Term Term of warrants or rights outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Investment, Name [Axis] Investment, Name [Axis] Allowances on accounts receivable Accounts Receivable, Allowance for Credit Loss, Current Application service providers Application Service Provider [Member] Represents a contractual commitment to application service providers. Issuance of common stock for bonus (in shares) Stock Issued During Period Shares Bonus Number of shares of stock issued attributable to bonus. Investments [Domain] Investments [Domain] Operating lease liabilities, long-term portion Operating lease liabilities, long-term portion Operating Lease, Liability, Noncurrent Balance Sheet Related Disclosures [Abstract] Balance Sheet Related Disclosures [Abstract] Issuance of common stock for IPR&D milestone Stock Issued Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract] Name of Property [Domain] Name of Property [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Entity Registrant Name Entity Registrant Name Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Accrued third-party service fees Accrued Specimen Service Fees Carrying value as of the balance sheet date of obligations incurred through that date and payable for specimen service fees. Schedule of RSU and Performance-Based Award Activity Share-Based Compensation Arrangements by Share-Based Payment Award, Restricted Stock Units, Vested and Expected to Vest [Table Text Block] Awards granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Total cost and expenses Costs and Expenses Awards forfeited/cancelled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Related Party Transaction [Line Items] Related Party Transaction [Line Items] Document Quarterly Report Document Quarterly Report Boulder, CO Lease Boulder, CO Lease [Member] Boulder, CO Lease Provision for (Reversal of) expected credit losses Provision for Loan, Lease, and Other Losses Total financial assets Assets, Fair Value Disclosure Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Counterparty Name [Domain] Counterparty Name [Domain] Investment in equity securities without readily determinable fair value Equity Securities without Readily Determinable Fair Value, Amount 2028 Lessee, Operating Lease, Liability, to be Paid, Year Two Number of operating segments Number of Operating Segments Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Machinery and equipment Machinery and Equipment [Member] Investment Type [Axis] Investment Type [Axis] Awards granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Revenue recognized during the period included in deferred revenues at the beginning of the period Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Measure of Progress Schedule of Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Restatement Determination Date: Restatement Determination Date [Axis] Non-PEO NEO Non-PEO NEO [Member] Accounts Receivable Accounts Receivable [Member] Credit loss reserve Debt Securities, Available-for-Sale, Allowance for Credit Loss Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Interest expense Interest Expense, Debt Stockholder representative allocable expenses Business Combination, Consideration Transferred, Tangible and Intangible Assets, Excluding Cash Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Gross Unrealized Gain Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Name Trading Arrangement, Individual Name Beginning balance Total Financing Receivable, Allowance for Credit Loss All Award Types Award Type [Domain] 2027 Lessee, Operating Lease, Liability, to be Paid, Year One Equity Awards Adjustments Equity Awards Adjustments [Member] Leasehold improvements Leasehold Improvements [Member] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Compensation Amount Outstanding Recovery Compensation Amount Schedule of Total Revenue by Geographic Area Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block] Cancellation of escrow shares pursuant to business combination, net Escrow Shares Cancelled, Value Escrow Shares Cancelled, Value CareDX Patent Case CareDX Patent Case [Member] Represents CareDX Patent Case. Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Extended billing collection period (in months) Extended Billing Collection Period Represents the extended collection period for billing. Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Revenue recognized Contract with Customer, Liability, Revenue Recognized Accrued compensation Increase (Decrease) in Employee Related Liabilities Americas, excluding U.S. Americas, Excluding United States [Member] Continents of North and South America, excluding the United States of America (US). Loss contingency, number of patents allegedly infringed Loss Contingency, Patents Allegedly Infringed, Number Fair value of common stock issued to Foresight Diagnostics shareholders Business Combination, Consideration Transferred, Equity Interest Preferred Stock Preferred Stock [Member] Schedule of Allowance for Doubtful Accounts Accounts Receivable, Allowance for Credit Loss [Table Text Block] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Name Awards Close in Time to MNPI Disclosures, Individual Name Asset acquisition, consideration transferred, transaction cost Asset Acquisition, Consideration Transferred, Transaction Cost Balance (in dollars per share) Balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Revaluation of contingent consideration Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Employee stock purchase plan Employee Stock [Member] Revenues Revenues [Abstract] Gain contingency, number of patents allegedly infringed Gain Contingency, Patents Allegedly Infringed upon, Number Schedule of Revenue by Payer Type Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block] Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Goodwill Goodwill, Gross Long-Term Purchase Commitment [Line Items] Long-Term Purchase Commitment [Line Items] Settlement of preexisting relationships Business Combination Consideration Transferred Settlement Of Preexisting Relationships Business Combination Consideration Transferred Settlement Of Preexisting Relationships Financial Instruments [Domain] Financial Instruments [Domain] Litigation Case [Axis] Litigation Case [Axis] Segments [Domain] Segments [Domain] Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Axis] Europe, Middle East, India, Africa EMEA [Member] PSU's Performance Shares [Member] Remaining borrowing capacity Line of Credit Facility, Remaining Borrowing Capacity Number of shares deposited in escrow (in shares) Number Of Shares Deposited In Escrow Account For Purchase Price Adjustments Number Of Shares Deposited In Escrow Account For Purchase Price Adjustments Financial Instruments Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Amortization of premiums and accretion of purchase discounts on investment securities Premium Amortization And Discount Accretion On Investment Securities Amount of premium amortization and discount accretion on investment securities. Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Inventory Increase (Decrease) in Inventories Inventory Inventory, Net Developed technology Developed Technology Rights [Member] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Minimum Minimum [Member] Number of common stock shares called by warrants (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Less: Accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Goodwill, measurement period adjustment Goodwill, Measurement Period Adjustment Company Selected Measure Name Company Selected Measure Name Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Purchase Commitment, Excluding Long-Term Commitment [Domain] Purchase Commitment, Excluding Long-Term Commitment [Domain] Accounts payable Accounts Payable, Current Operating lease payments Operating Lease, Payments Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Liabilities assumed Business Combination, Recognized Liability Assumed, Liability All Executive Categories All Executive Categories [Member] Common stock, $0.0001 par value: 750,000 shares authorized at both March 31, 2026 and December 31, 2025; 142,734 and 139,693 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Amortization of non-cash liability Amortization of Non Cash Liability Amount of amortization of non-cash liability. Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Commitments and contingencies (Note 10) Commitments and Contingencies Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Business Combination [Axis] Business Combination [Axis] Entity Small Business Entity Small Business Stock issuance costs Payments of Stock Issuance Costs Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Number of patents found infringed Loss Contingency, Patents Found Infringed, Number Class action Class Action Lawsuit [Member] Lawsuit where one of the parties is a group of people who are represented collectively by a member or members of that group. Policies Restricted Cash and Cash Equivalent Item [Line Items] Adjustment, consideration transferred Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred Debt Long-Term Debt [Text Block] Document Transition Report Document Transition Report Issuance of common stock for bonus Issuance of common stock for bonuses APIC, Share-Based Payment Arrangement, Other, Increase for Cost Recognition Other assets Business Combination, Recognized Asset Acquired, Other Asset, Noncurrent Ownership percentage Equity Method Investment, Ownership Percentage Underlying Securities Award Underlying Securities Amount Concentration Risk [Line Items] Concentration Risk [Line Items] Equity Component [Domain] Equity Component [Domain] Document Period End Date Document Period End Date PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Income Taxes Income Tax Disclosure [Text Block] Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Decrease in amount awarded from other party Litigation Settlement, Increase (Decrease) in Amount Awarded from Other Party Litigation Settlement, Increase (Decrease) in Amount Awarded from Other Party Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Assets Acquired From Invitae Assets Acquired From Invitae [Member] Assets Acquired From Invitae Property and equipment purchases Accrued Fixed Asset Purchases Carrying value as of the balance sheet date of obligations incurred and payable for fixed assets. Deferred tax liability Business Combination, Recognized Liability Assumed, Deferred Tax Liability Foresight Diagnostics’ transaction expenses settled by the Company Business Combination Consideration Transferred Transaction Expenses Settled By Company Business Combination Consideration Transferred Transaction Expenses Settled By Company Operating lease liabilities Increase (Decrease) in Operating Lease Liability Document Type Document Type Level 3 Fair Value, Inputs, Level 3 [Member] Net Loss per Share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Loss Contingencies [Table] Loss Contingencies [Table] Product and Service [Axis] Product and Service [Axis] Asset Acquisition [Domain] Asset Acquisition [Domain] Additional Space San Carlos, California Additional Space San Carlos, California [Member] Additional Space San Carlos, California Total revenues Revenue Revenue from Contract with Customer, Excluding Assessed Tax Insurance carriers Insurance Carriers [Member] Insurance carriers group of customers. All Individuals All Individuals [Member] Long-Term Debt, Type [Domain] Long-Term Debt, Type [Domain] Sales and income tax payable Sales and Excise Tax Payable Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Purchases of property and equipment, net Payments to Acquire Property, Plant, and Equipment Asset acquisition, consideration transferred Asset Acquisition, Consideration Transferred Name Forgone Recovery, Individual Name Austin, TX Additional Premises Lease Austin, TX Additional Premises Lease [Member] Austin, TX Additional Premises Lease Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Developed Technology Developed Technology [Member] Developed Technology Laboratory partners Laboratory Partners [Member] Laboratory and other partners group of customers. Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Pre-combination portion of Natera replacement equity awards Business Combination Consideration Transferred Company Replacement Equity Awards Business Combination Consideration Transferred Company Replacement Equity Awards Non-cash interest expense Non Cash Interest Expense Amount of non-cash interest expense. Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Asset acquisition, consideration transferred, contingent consideration Asset Acquisition, Consideration Transferred, Contingent Consideration Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Intangible Asset, Finite-Lived [Table] Intangible Asset, Finite-Lived [Table] Net unrealized gain on available-for-sale securities, net of tax and foreign currency translation adjustment Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Current liabilities: Liabilities, Current [Abstract] Geographical [Axis] Geographical [Axis] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Share price (in dollars per shares) Business Combination, Price Per Share Level 1 Fair Value, Inputs, Level 1 [Member] Stock based compensation expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Foreign exchange adjustment Gain (Loss), Foreign Currency Transaction, before Tax Related Party Transaction [Table] Related Party Transaction [Table] Diluted (in dollars per share) Earnings Per Share, Diluted Other accrued liabilities Increase (Decrease) in Other Accrued Liabilities Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Potential future milestone obligations Potential Future Milestone Obligations Potential Future Milestone Obligations Accounts receivable, net of allowance of $7,927 and $8,018 at March 31, 2026 and December 31, 2025, respectively Accounts Receivable, after Allowance for Credit Loss, Current Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Title of 12(b) Security Title of 12(b) Security Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Acquisition of warrants and warrants receivable Acquisition of Warrants and Warrants Receivable Amount of warrants acquired. Non-cash investing and financing activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] AOCI Attributable to Parent, Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Net loss per share (Note 14): Earnings Per Share [Abstract] Clinical trials and studies Accrued Clinical Trials And Studies Carrying value as of the balance sheet date of obligations incurred through that date and payable for clinical trials and studies. Investments, Debt and Equity Securities [Abstract] Investments, Debt and Equity Securities [Abstract] Gross margin Gross Profit Schedule of Total Outstanding Potentially Dilutive Shares Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Deferred revenue Increase (Decrease) in Contract with Customer, Liability Accumulated Other Comprehensive Income (Loss) Comprehensive Income, Policy [Policy Text Block] Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Aggregate grant date fair value, target vesting percentage Share Based Compensation Arrangement By Share Based Payment Award, Award Vesting Target, Aggregate Grant Date Fair Value, Percentage Share Based Compensation Arrangement By Share Based Payment Award, Award Vesting Target, Aggregate Grant Date Fair Value, Percentage Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Two Award Timing Disclosures [Line Items] Accrued compensation Employee-related Liabilities, Current Movement in Contract With Customer Liability [Roll Forward] Movement in Contract With Customer Liability [Roll Forward] Movement in Contract With Customer Liability Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Renewal term of lease Lessee, Operating Lease, Renewal Term Net loss Net loss Net loss Net Income (Loss) Attributable to Parent Gain contingency, number of patents found infringed Gain Contingency, Patents Found Infringed upon, Number Expiration Date Trading Arrangement Expiration Date Construction-in-process Construction in Progress [Member] Number of office space locations Lessee, Operating Lease, Number of Office Spaces Represents the number of office spaces. Restrictions on Cash and Cash Equivalents [Table] Restrictions on Cash and Cash Equivalents [Table] Property and equipment, net Total property and equipment, net Property, Plant and Equipment, Net Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Adoption Date Trading Arrangement Adoption Date Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Accounts receivable Increase (Decrease) in Accounts Receivable Inventory Inventory, Policy [Policy Text Block] Entity Current Reporting Status Entity Current Reporting Status Term of lease Lessee, Operating Lease, Term of Contract Customer [Axis] Customer [Axis] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Customer-relationships Customer Relationships [Member] Loss from operations Operating Income (Loss) Line of Credit Line of Credit [Member] Other accrued expenses Other Accrued Sundry Expenses Current Amount of expenses not otherwise itemized or categorized in the footnotes to the financial statements that have been incurred but not yet paid, due within one year or the normal operating cycle, if longer. Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Name of Property [Axis] Name of Property [Axis] Second Space San Carlos, California Second Space San Carlos, California [Member] Second Space San Carlos, California Financial Instrument [Axis] Financial Instrument [Axis] Adjustments to reconcile net loss to net cash provided by operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Noncash Item [Abstract] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Executive Category: Executive Category [Axis] Class of Stock [Axis] Class of Stock [Axis] Current Fiscal Year End Date Current Fiscal Year End Date Other material suppliers Other Material Supplier [Member] Represents a contractual commitment to purchase from suppliers. Subsequent Event Type [Domain] Subsequent Event Type [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Number of lawsuits consolidated Loss Contingency, Number of Lawsuits Consolidated Loss Contingency, Number of Lawsuits Consolidated Weighted- Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Interest and other income, net Other Nonoperating Income (Expense) Statement [Table] Statement [Table] Stock-based compensation included in capitalized software development costs Stock Based Compensation Included In Capitalized Software Development Costs Amount of stock-based compensation included in capitalized software development costs. Schedule of Consideration Transferred Business Combination [Table Text Block] Financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] ArcherDX Case ArcherDX Patent Case [Member] Represents ArcherDX Patent Case. Revenue Benchmark Revenue Benchmark [Member] Total Foresight Diagnostics consideration Total Foresight Diagnostics consideration Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill Deferred revenue Beginning balance Ending balance Contract with Customer, Liability Summary of Financial Assets and Liabilities Measured on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Description of Business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Issuance of common stock pursuant to asset acquisition, net Stock Issued During Period, Value, Acquisitions Potentially dilutive shares not included in diluted per share calculation (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Weighted-average number of shares used in computing basic and diluted net loss per share: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Unrealized gain on available-for-sale securities, net of tax and foreign currency translation adjustment Unrealized Gain Or Loss On Available For Sale Securities And Foreign Currency Translation Adjustment Unrealized Gain Or Loss On Available For Sale Securities And Foreign Currency Translation Adjustment All Adjustments to Compensation All Adjustments to Compensation [Member] Amendment Flag Amendment Flag Leases Lessee, Operating Leases [Text Block] Termination Date Trading Arrangement Termination Date Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Measure: Measure [Axis] Reportable Segment Reportable Segment [Member] Represents a single reportable segment. Weighted average discount rate (as a percent) Operating Lease, Weighted Average Discount Rate, Percent Summary of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Total drawn down Aggregate Proceeds from Line of Credit Aggregate Proceeds from Line of Credit Interest and penalties accrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Stock-based compensation, milestones as a percentage of grant value Share Based Compensation Arrangement By Share Based Payment Award, Share Based Compensation Milestones as a Percentage of Grant Value Share-based compensation, milestones as a percentage of grant value. Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Vesting of restricted stock units Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Basic (in shares) Weighted Average Number of Shares Outstanding, Basic Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Cost of revenues Cost of Product and Service Sold Foresight Diagnostics, Inc. Foresight Diagnostics, Inc. [Member] Foresight Diagnostics, Inc. Subsequent Events [Abstract] Subsequent Events [Abstract] Segment Reporting [Abstract] Segment Reporting [Abstract] Year ending December 31: Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] Customer relationships intangible asset Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Customer Relationships Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Customer Relationships Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Entity Tax Identification Number Entity Tax Identification Number Cost and expenses Costs and Expenses [Abstract] Asset Acquisition [Axis] Asset Acquisition [Axis] Licensing and other revenues Licensing and Other [Member] Licensing and other services. Legal, audit and consulting fees Accrued Professional Fees Outstanding, beginning balance (in dollars per share) Outstanding, end balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Stock Based Compensation Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares issued (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Issued Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Trademarks / trade names intangible asset Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Trademarks And Trade Names Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Trademarks And Trade Names Goodwill and Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Fair value of total principal outstanding and accrued interest Outstanding balance Line of Credit Facility, Fair Value of Amount Outstanding Use of Estimates Use of Estimates, Policy [Policy Text Block] Amount awarded to other party Litigation Settlement, Amount Awarded to Other Party Interest expense Interest Expense, Nonoperating Trading Arrangement: Trading Arrangement [Axis] Total Shareholder Return Amount Total Shareholder Return Amount Loss Contingencies [Line Items] Loss Contingencies [Line Items] 2031 and thereafter Lessee, Operating Lease, Liability, to be Paid, Due After Year Four Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year and after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Subsequent Events Subsequent Events [Text Block] Insider Trading Arrangements [Line Items] Security Exchange Name Security Exchange Name Forfeited/cancelled (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Matthew Rabinowitz Matthew Rabinowitz [Member] Matthew Rabinowitz Testing and laboratory materials from suppliers Accrued Testing And Laboratory Materials From Suppliers Carrying value as of the balance sheet date of obligations incurred through that date and payable for testing and laboratory materials from suppliers. Total liabilities Liabilities Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Business Combination, Separately Recognized Transaction [Line Items] Business Combination, Separately Recognized Transaction [Line Items] Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Target (percentage) Share Based Compensation Arrangement By Share Based Payment Award, Award Vesting Target, Percentage Target percentage for vesting of award under share-based payment arrangement. Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Other accrued liabilities Total other accrued liabilities Other Liabilities, Current Ongoing royalty percentage Litigation Settlement, Amount Awarded from Other Party, Ongoing Royalty Percentage Litigation Settlement, Amount Awarded from Other Party, Ongoing Royalty Percentage 2031 and thereafter Finite-Lived Intangible Asset, Expected Amortization, after Year Four Finite-Lived Intangible Asset, Expected Amortization, after Year Four Operating lease right-of-use assets Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Operating Lease Right Of Use Assets Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Operating Lease Right Of Use Assets Statement [Line Items] Statement [Line Items] Cloud platform service provider Cloud Platform Service Provider [Member] Represents a contractual commitment to cloud platform service provider. Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Counterparty Name [Axis] Counterparty Name [Axis] Common Stock Common Stock [Member] Awards vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Estimated Fair Value Debt Securities, Available-for-Sale Unrealized gain on available-for sale securities, net of tax and foreign currency translation adjustment OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Non-NEOs Non-NEOs [Member] Net change in cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Oncology Oncology [Member] Represents oncology assay interpretation services.